Health Innovation Research


Cholesterol Study

Do you have, or think you have elevated cholesterol? Visit us for a free cholesterol test and check your eligibility for our study.

Check your eligibility here

If you have (or think you have) elevated cholesterol, you could help research.

RDC Global is conducting a study to evaluate the effect of orally-dosed Almega PL on cardio-metabolic parameters and inflammatory markers in men and women with hypercholesterolemia.


Hypercolesterolemia is elevated cholesterol in the blood and is a well-known risk factor for cardiovascular diseases. Almega PL is a type of omega-3 essential fatty acid derived from microalgae. Omega-3 essential fats cannot be made by the body and must be consumed in the diet or via supplementation. Omega-3 essential fatty acids are known to have a beneficial effect on cholesterol levels and may offer protection against cardiovascular diseases.

About the study...assessing lowering cholesterol

Potential participants will be screened for inclusion in the study. You will then be enrolled and asked to attend the study site, fill out questionnaires, have a finger prick test, undertake a body composition assessment and be allocated to the treatment group or placebo.

Following this you will undertake a blood test and be asked to take the allocated product daily for 6 months and to attend the study site every 2 months for an assessment. Each assessment will involve filling out questionnaires, undertaking a progress interview and having a finger prick test. You are also required to undertake a blood test at months 2 and 4.

At the end of the study, you will also be asked to attend the study site to complete questionnaires, body composition assessment, exit interview and you will be asked to have a final blood test.

Check if you can take participant requirements.
  • Male and females over 25 years with hypercholesterolemia
  • Normal dietary habits (eg no special diet such as vegan or macrobiotic)
  • Othewise healthy, BMI (18.5-29.9)
  • A Body Mass Index (BMI)  between 18.5 and 29.9
  • Participant’s full agreement and ability to consent to participation in the study.
Your rights and privacy.

Your rights relating to this study and any other information received will be kept strictly confidential. Upon completion, the results of the study will be shared with you.

About the location of the'll attend clinic appointments

RDC Global Pty Ltd
3B/76 Doggett Street, Newstead, QLD 4006

We are walking distance from the Commercial Road Ferry Terminal & local buses, and a short walk from Bowen Hills train station. We have onsite visitor parking available during your visits.

Share This